Literature DB >> 34859468

Relationship between pre-pregnancy maternal body mass index and infant weight trajectories in HIV-exposed and HIV-unexposed infants.

Angela M Bengtson1, Stanzi M le Roux2, Tamsin K Phillips2,3, Kirsty Brittain2,3, Allison Zerbe4, Hlengiwe P Madlala2, Thokozile R Malaba2,3, Gregory Petro5, Elaine J Abrams4,6, Landon Myer2,3.   

Abstract

BACKGROUND: Maternal HIV and antiretroviral therapy (ART) exposure in utero may influence infant weight, but the contribution of maternal y body mass index (BMI) to early life overweight and obesity is not clear.
OBJECTIVE: To estimate associations between maternal BMI at entry to antenatal care (ANC) and infant weight through approximately 1 year of age and to evaluate whether associations were modified by maternal HIV status, maternal HIV and viral load, breastfeeding intensity through 6 months or timing of entry into ANC.
METHODS: We followed HIV-uninfected and -infected pregnant women initiating efavirenz-based ART from first antenatal visit through 12 months postpartum. Infant weight was assessed via World Health Organization BMI and weight-for-length z-scores (WLZ) at 6 weeks, 3, 6, 9 and 12 months. We used multivariable linear mixed-effects models to estimate associations between maternal BMI and infant z-scores over time.
RESULTS: In 861 HIV-uninfected infants (454 HIV-exposed; 407 HIV-unexposed), nearly 20% of infants were overweight or obese by 12 months of age, regardless of HIV exposure status. In multivariable analyses, increasing maternal BMI category was positively associated with higher infant BMIZ and WLZ scores between 6 weeks and 12 months of age and did not differ by HIV exposure status. However, HIV-exposed infants had slightly lower BMIZ and WLZ trajectories through 12 months of age, compared with HIV-unexposed infants across all maternal BMI categories. Differences in BMIZ and WLZ scores by HIV exposure were not explained by timing of entry into ANC or maternal viral load pre-ART initiation, but z-scores were slightly higher for HIV-exposed infants who were predominantly or exclusively versus partially breastfed.
CONCLUSIONS: These findings suggest maternal BMI influences early infant weight gain, regardless of infant HIV exposure status. Intervention to reduce maternal BMI may help to address growing concerns about obesity among HIV-uninfected children.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  BMI; HIV; HIV-exposed; South Africa; infant growth; infant weight

Mesh:

Year:  2021        PMID: 34859468      PMCID: PMC9163208          DOI: 10.1111/ppe.12825

Source DB:  PubMed          Journal:  Paediatr Perinat Epidemiol        ISSN: 0269-5022            Impact factor:   3.103


  50 in total

1.  Infant BMI or Weight-for-Length and Obesity Risk in Early Childhood.

Authors:  Sani M Roy; Jordan G Spivack; Myles S Faith; Alessandra Chesi; Jonathan A Mitchell; Andrea Kelly; Struan F A Grant; Shana E McCormack; Babette S Zemel
Journal:  Pediatrics       Date:  2016-05       Impact factor: 7.124

2.  Decelerated early growth in infants of overweight and obese mothers.

Authors:  Katie Larson Ode; Heather L Gray; Sara E Ramel; Michael K Georgieff; Ellen W Demerath
Journal:  J Pediatr       Date:  2012-07-20       Impact factor: 4.406

3.  Growth trajectories of breastfed HIV-exposed uninfected and HIV-unexposed children under conditions of universal maternal antiretroviral therapy: a prospective study.

Authors:  Stanzi M le Roux; Elaine J Abrams; Kirsten A Donald; Kirsty Brittain; Tamsin K Phillips; Kelly K Nguyen; Allison Zerbe; Max Kroon; Landon Myer
Journal:  Lancet Child Adolesc Health       Date:  2019-02-15

4.  Changes in insulin sensitivity over time and associated factors in HIV-infected adolescents.

Authors:  Mitchell E Geffner; Kunjal Patel; Denise L Jacobson; Julia Wu; Tracie L Miller; Rohan Hazra; Mariana Gerschenson; Tanvi Sharma; Margarita Silio; Jennifer Jao; Jody K Takemoto; Russell B Van Dyke; Linda A DiMeglio
Journal:  AIDS       Date:  2018-03-13       Impact factor: 4.177

5.  Predictors of Infant Body Composition at 5 Months of Age: The Healthy Start Study.

Authors:  Katherine A Sauder; Jill L Kaar; Anne P Starling; Brandy M Ringham; Deborah H Glueck; Dana Dabelea
Journal:  J Pediatr       Date:  2017-02-01       Impact factor: 4.406

6.  Influence of maternal obesity on the association between common pregnancy complications and risk of childhood obesity: an individual participant data meta-analysis.

Authors:  Bernadeta Patro Golab; Susana Santos; Ellis Voerman; Debbie A Lawlor; Vincent W V Jaddoe; Romy Gaillard
Journal:  Lancet Child Adolesc Health       Date:  2018-09-07

7.  Risk factors and outcomes of maternal obesity and excessive weight gain during pregnancy.

Authors:  Romy Gaillard; Büşra Durmuş; Albert Hofman; Johan P Mackenbach; Eric A P Steegers; Vincent W V Jaddoe
Journal:  Obesity (Silver Spring)       Date:  2013-05       Impact factor: 5.002

8.  Growth of HIV-Exposed Uninfected Infants in the First 6 Months of Life in South Africa: The IeDEA-SA Collaboration.

Authors:  Erna Morden; Karl-Günter Technau; Janet Giddy; Nicola Maxwell; Olivia Keiser; Mary-Ann Davies
Journal:  PLoS One       Date:  2016-04-06       Impact factor: 3.240

9.  Integration of postpartum healthcare services for HIV-infected women and their infants in South Africa: A randomised controlled trial.

Authors:  Landon Myer; Tamsin K Phillips; Allison Zerbe; Kirsty Brittain; Maia Lesosky; Nei-Yuan Hsiao; Robert H Remien; Claude A Mellins; James A McIntyre; Elaine J Abrams
Journal:  PLoS Med       Date:  2018-03-30       Impact factor: 11.069

10.  Same-day antiretroviral therapy (ART) initiation in pregnancy is not associated with viral suppression or engagement in care: A cohort study.

Authors:  Nontokozo Langwenya; Tamsin K Phillips; Kirsty Brittain; Allison Zerbe; Elaine J Abrams; Landon Myer
Journal:  J Int AIDS Soc       Date:  2018-06       Impact factor: 5.396

View more
  1 in total

1.  Beyond COVID-19: Equitable epidemiology for studying the impact of maternal infections on neonatal mortality and morbidity.

Authors:  Stephanie Jones; Marta Coelho Nunes
Journal:  Paediatr Perinat Epidemiol       Date:  2022-07       Impact factor: 3.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.